Fig. 4

Kaplan–Meier curves of (a) early recurrence-free survival in the surgery outcome cohort and (b) progression-free survival in the transarterial chemoembolization (TACE) outcome cohort. The early recurrence-free survival and progression-free survival were estimated using scores derived from the radiomics nomogram